Quantcast

Latest Cancer stem cell Stories

2014-01-28 12:29:54

DUBLIN, Ireland, January 28, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/kdgxkz/opportunities_in) has announced the addition of the "Human Embryonic Stem Cell (hESC) Products Industry - Opportunities and Forecasts to 2017" [http://www.researchandmarkets.com/research/kdgxkz/opportunities_in ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Stem cells are primitive cells found in all...

2014-01-27 10:35:28

Researchers from Melbourne's Walter and Eliza Hall Institute have discovered that breast stem cells and their 'daughters' have a much longer lifespan than previously thought, and are active in puberty and throughout life. The longevity of breast stem cells and their daughters means that they could harbour genetic defects or damage that progress to cancer decades later, potentially shifting back the timeline of breast cancer development. The finding is also integral to identifying the...

2014-01-20 23:03:53

GIA announces the release of a trend report on Cancer Stem Cells. Market for Cancer Stem Cells is projected to witness strong growth led by high prevalence of cancer worldwide, unmet medical needs in cancer treatment and diagnosis, strong investments in R&D, and supportive regulatory and reimbursement policies. San Jose, California (PRWEB) January 20, 2014 Follow us on LinkedIn – Cancer Stem Cells (CSCs) are the cells within a tumor that possess the capability of self-renewal,...

2014-01-14 11:05:11

Johns Hopkins scientists say a previously known but little studied chemical compound targets and shuts down a common cancer process. In studies of laboratory-grown human tumor cell lines, the drug disrupted tumor cell division and prevented growth of advanced cancer cells. In a study described in the January 13 issue of Cancer-Cell, Marikki Laiho, M.D., Ph.D., and her colleagues say their work focused on the ability of a chemical dubbed BMH-21 to sabotage the transcription pathway RNA...

2014-01-13 08:29:57

CAMBRIDGE, Mass., Jan. 13, 2014 /PRNewswire/ -- Cerulean Pharma Inc., a leader in dynamically tumor-targeted nanopharmaceuticals, today announced that CRLX101 has achieved its primary efficacy endpoint in an ongoing single-arm Phase 2 monotherapy clinical trial in relapsed ovarian cancer. The ongoing open label Phase 2 monotherapy trial is being conducted at Massachusetts General Hospital and the affiliated Harvard teaching hospitals under the direction of principal investigator,...

2014-01-07 13:47:40

In recent years, non-hematopoietic effects of erythropoietin (EPO), via its binding to the EPO receptor in non-hematopoietic tissues, including cancerous tissues, has been reported by many different laboratories worldwide. However, it remains controversial concerning whether EPO, particularly recombinant EPO that is used to treat anemia in patients, may promote cancer cell proliferation and survival. In this paper, the authors show evidence indicating the presence of autocrine/paracrine...

2013-12-10 23:24:33

Jacco van Rheenen, Ph.D., of the Hubrecht Institute in The Netherlands has been named the winner of the 8th Annual STEM CELLS Young Investigator Award for his investigation on how healthy and tumorigenic tissues are derived from and maintained by cancer stem cells, how tumor cells disseminate from primary tumors and how these disseminated tumor cells grow out in distant organs. Durham, NC (PRWEB) December 10, 2013 Jacco van Rheenen, Ph.D., of the Hubrecht Institute in The Netherlands has...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.